Sara Gobbato
Schlieren, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice.
Journal: Thrombosis research
Published: December 08, 2022
Dietary alpha-linolenic acid reduces platelet activation and collagen-mediated cell adhesion in sickle cell disease mice.
Journal: Journal of thrombosis and haemostasis : JTH
Published: May 21, 2021
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism.
Journal: Thrombosis research
Published: September 25, 2018
In response to the comment by Hechler et al.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance.
Journal: Haematologica
Published: December 02, 2017
Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance.
Journal: Haematologica
Published: January 09, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026